Dr. Zilbermint is a board-certified Endocrinologist. He received his medical degree from the State Medical and Pharmaceutical University N. Testemitanu, Moldova. He completed his Internal Medicine training at Saint Agnes Hospital, Baltimore, MD. Zilbermint joined the Endocrinology Fellowship at National Institute of Health in July 2012.
During his work at the Section on Endocrinology and Genetics, NICHD, he developed a particular interest in rare genetic diseases. He was the first to describe and publish the clinical phenotype of the NIH cohort of patients with novel mutations in ARMC5 gene, which can cause macronodular adrenal hyperplasia and Cushing’s syndrome. Zilbermint was invited to share this discovery as an oral presentation at the International Congress of Endocrinology/ Endocrine Society’s 96th Annual Meeting in Chicago, IL in June 2014. He is currently interested in exploring whether the ARMC5 gene plays a role in other endocrinopathies.
Dr. Zilbermint is an associate clinical investigator in the following NIH clinical research studies: “A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalamic Disorders”, “Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue”, and “Evaluation of Patients with Endocrine-Related Conditions”.
Dr. Zilbermint received awards and grants from European Society of Endocrinology, International Society of Endocrinology and Endocrine Society. He is an active volunteer at a camp for children with type I diabetes.